Senior Lecturer
Anatomy & Neuroscience
3.85
Western Gateway Building
Western Road
Cork

T: +353 21 4205427
E: a.sullivan@ucc.ie
Web Page
Senior Lecturer
Department of Anatomy & Neuroscience
University College Cork
Cork
Ireland

T: +353-21-490-3000
F: +353 21 490 2385
E: A.Sullivan@ucc.ie
Web Page

Dr Aideen Sullivan leads an active research group, based in the Biosciences Institute at University College, Cork. Her research is focused on novel approaches to the treatment of Parkinson's disease, in particular neuroprotective therapies, which have the potential to slow or even reverse the progression of this disease. Her research programme is funded by the Health Research Board and the Irish Research Council for Science Engineering and Technology.

Dr Sullivan graduated from University College Dublin in 1992 with a BSc (Hons) in Pharmacology. She obtained a PhD in Neuropharmacology from the University of Cambridge, UK, in 1995. She worked in the Imperial College School of Medicine, London, as a post-doctoral researcher from 1995-1998, on a project funded by the Parkinson's Disease Society. In 1998, she was appointed as Lecturer in the Department of Anatomy at UCC and was promoted to Senior Lecturer in 2006. She was involved in establishing the BSc (Hons) in Neuroscience at UCC- the first Neuroscience degree in Ireland - and she has been active in teaching and co-ordinating this degree course since her appointment to UCC. In 2006, she was awarded a Postgraduate Certificate in Teaching and Learning in Higher Education from UCC.  She practices research-led teaching and encourages capable students to pursue research careers. She provides mentoring to undergraduate and postgraduate students and to colleagues. In 201, she attained a FETAC cert (awarded Distinction) in Peer-mentoring.

Dr Sullivan is active in promoting Neuroscience and stem cell research in Ireland. As a member of the Cork Neuroscience Group committee, she is presently organising a series of public awareness talks in UCC about current research and treatments for neurological diseases. She visits PD patient and carer groups, and clinicians and nurses who work with PD patients, to speak about her research, or recent advances in the research field. She is a member of Neuroscience Ireland, FENS (Federation of European Neurosciences), NECTAR (Network of European CNS Transplantation and Restoration), the Anatomical Society of Great Britain and Ireland, and the Irish Network of Neuronal Stem Cell Investigators.


In vitro and in vivo models of Parkinson's disease; Cell replacement strategies for Parkinsons disease, including the use of neural stem cells; Use of neurotrophins in neurodegenerative disorders; Roles of neurotrophins in the developing and adult brain; Neural stem cells for therapy in neurodegenerative disorders; Involvement of glial cells in Parkinson's disease; Mechanisms of cell death in Parkinson's disease.

Peer Reviewed Journals

 YearPublication
(2010)'Tumour necrosis factor-alpha impairs neuronal differentiation but not proliferation of hippocampal neural precursor cells: Role of Hes1'
Keohane, A; Ryan, S; Maloney, E; Sullivan, AM; Nolan YM ; (2010) 'Tumour necrosis factor-alpha impairs neuronal differentiation but not proliferation of hippocampal neural precursor cells: Role of Hes1' [Details]
(2010)'Interleukin-1β contributes to dopaminergic neuronal death induced by lipopolysaccharide-stimulated rat glia in vitro'
Long-Smith C., Collins L., Toulouse A., Sullivan A.M., Nolan Y.M.; (2010) 'Interleukin-1β contributes to dopaminergic neuronal death induced by lipopolysaccharide-stimulated rat glia in vitro' [Details]
(2010)'Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivo'
O'Sullivan, D.B., Harrison, P.T., Sullivan, A.M.; (2010) 'Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivo' [Details]
(2002)'TGF-[beta] and the regulation of neuron survival and death'
Krieglstein, Kerstin,Strelau, Jens,Schober, Andreas,Sullivan, Aideen,Unsicker, Klaus; (2002) 'TGF-[beta] and the regulation of neuron survival and death' Globe icon [Details]
(2008)'Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease'
Crotty S, Fitzgerald P, Tuohy E, Harris DM, Fisher A, Mandel A, Bolton AE, Sullivan AM, Nolan Y; (2008) 'Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease' [DOI] [Details]
(2008)'TAT-PAX6 protein transduction in neural progenitor cells: A novel approach for generation of dopaminergic neurones in vitro. Brain Research'
Spitere, Katie,Toulouse, André,O'Sullivan, David B.,Sullivan, Aideen M.; (2008) 'TAT-PAX6 protein transduction in neural progenitor cells: A novel approach for generation of dopaminergic neurones in vitro. Brain Research' Globe icon [Details]
(2008)'Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: implications for Parkinson's disease'
Fitzgerald P, Mandel A, Bolton AE, Sullivan AM, Nolan Y; (2008) 'Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: implications for Parkinson's disease' [DOI] [Details]
(2008)'Progress in Parkinson's disease--Where do we stand?. Progress in Neurobiology'
Toulouse, André,Sullivan, Aideen M.; (2008) 'Progress in Parkinson's disease--Where do we stand?. Progress in Neurobiology' Globe icon [Details]
(2007)'Differential Effects of Gdf5 On The Medial and Lateral Rat Ventral Mesencephalon'
Clayton, KB, Sullivan, AM; (2007) 'Differential Effects of Gdf5 On The Medial and Lateral Rat Ventral Mesencephalon' [DOI] [Details]
(2007)'Expression of the cell surface markers mAb 2F7 and PSA-NCAM in the embryonic rat brain. Neuroscience Letters'
Shanley, Daniel K.,Sullivan, Aideen M.; (2007) 'Expression of the cell surface markers mAb 2F7 and PSA-NCAM in the embryonic rat brain. Neuroscience Letters' Globe icon [Details]
(2006)'Alterations in cellular phenotypes differentiating from embryonic rat brain neurosphere cultures by immunoselection of neuronal progenitors'
Shanley DK, Sullivan AM; (2006) 'Alterations in cellular phenotypes differentiating from embryonic rat brain neurosphere cultures by immunoselection of neuronal progenitors' [Details]
(2005)'Differential effects of GDF5 and GDNF on dopaminergic neurones and astroglia in cultures of embryonic rat midbrain'
Wood, TK, McDermott, KW, Sullivan AM; (2005) 'Differential effects of GDF5 and GDNF on dopaminergic neurones and astroglia in cultures of embryonic rat midbrain' [Details]
(2005)'The role of growth/differentiation factor-5 in the induction and survival of midbrain dopaminergic neurones: relevance for Parkinson’s disease'
Sullivan AM, O’Keeffe GW; (2005) 'The role of growth/differentiation factor-5 in the induction and survival of midbrain dopaminergic neurones: relevance for Parkinson’s disease' [Details]
(2005)'Donor age affects differentiation of rat ventral mesencephalic stem cells'
O'Keeffe GW, Sullivan AM.; (2005) 'Donor age affects differentiation of rat ventral mesencephalic stem cells' [Details]
(2004)'Effects of growth/differentiation factor 5 on the survival and morphology of embryonic rat midbrain dopaminergic neurones in vitro'
O'Keeffe GW, Dockery P, Sullivan AM.; (2004) 'Effects of growth/differentiation factor 5 on the survival and morphology of embryonic rat midbrain dopaminergic neurones in vitro' [Details]
(2004)'Expression of the dopaminergic neurotrophin growth/differentiation factor-5 in the developing and adult rat brain'
O'Keeffe GW, Hanke M, Pohl J, Sullivan AM.; (2004) 'Expression of the dopaminergic neurotrophin growth/differentiation factor-5 in the developing and adult rat brain' [Details]
(2004)'Heparin-binding epidermal growth factor-like growth factor : A component in chromaffin granules which promotes the survival of nigrostriatal dopaminergic neurones in vitro and in vivo'
Hanke M, Farkas L, Jakob M, Ries R, Pohl J, Sullivan AM.; (2004) 'Heparin-binding epidermal growth factor-like growth factor : A component in chromaffin granules which promotes the survival of nigrostriatal dopaminergic neurones in vitro and in vivo' [Details]
(2004)'Neuroprotective effects of delayed administration of growth/differentiation factor-5 in the partial lesion model of Parkinson’s disease'
Hurley FM, Costello DJ, Sullivan AM.; (2004) 'Neuroprotective effects of delayed administration of growth/differentiation factor-5 in the partial lesion model of Parkinson’s disease' [Details]
(2003)'Growth/differentiation factor-15 (GDF-15), a novel member of the TGF-beta superfamily, promotes survival of lesioned mesencephalic dopaminergic neurons in vitro and in vivo and is induced in neurons following cortical lesioning. Journal of Neural Transmission-Supplement'
Strelau, J.,Schober, A.,Sullivan, A.,Schilling, L.,Unsicker, K.; (2003) 'Growth/differentiation factor-15 (GDF-15), a novel member of the TGF-beta superfamily, promotes survival of lesioned mesencephalic dopaminergic neurons in vitro and in vivo and is induced in neurons following cortical lesioning. Journal of Neural Transmission-Supplement' Globe icon [Details]
(2000)'Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. Journal of Neuroscience'
Strelau, J.,Sullivan, A.,Bottner, M.,Lingor, P.,Falkenstein, E.,Suter-Crazzolara, C.,Galter, D.,Jaszai, J.,Krieglstein, K.,Unsicker, K.; (2000) 'Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. Journal of Neuroscience' Globe icon [Details]
(1999)'Neuroprotective effects of growth/differentiation factor 5 depend on the site of administration'
Sullivan AM, Opacka-Juffry J, Pohl J, Blunt SB.; (1999) 'Neuroprotective effects of growth/differentiation factor 5 depend on the site of administration' [Details]
(1998)'Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo'
Sullivan AM, Opacka-Juffry J, Blunt SB.; (1998) 'Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo' [Details]
(1998)'Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson’s disease'
Sullivan AM, Pohl J, Blunt SB.; (1998) 'Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson’s disease' [Details]
(1997)'Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease'
Sullivan AM, Opacka-Juffry J, Hotten G, Pohl J, Blunt SB.; (1997) 'Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease' [Details]
(1996)'Endothelins induce Fos expression in neurons and glia in organotypic cultures of rat cerebellum'
Sullivan AM, Morton AJ.; (1996) 'Endothelins induce Fos expression in neurons and glia in organotypic cultures of rat cerebellum' [Details]
(1996)'Lack of permanent nigrostriatal dopamine deficit following 6-hydroxydopamine injection into the rat striatum'
Opacka-Juffry J, Ashworth S, Sullivan AM, Banati RB, Blunt SB.; (1996) 'Lack of permanent nigrostriatal dopamine deficit following 6-hydroxydopamine injection into the rat striatum' [Details]
(1996)'Cortical induction of c-fos by intrastriatal endothelin-1 is mediated via NMDA receptors'
Sullivan AM, Reynolds DS, Thomas KL, Morton AJ.; (1996) 'Cortical induction of c-fos by intrastriatal endothelin-1 is mediated via NMDA receptors' [Details]

Conference Publications

 YearPublication
(2008)2nd Neuroscience Ireland Conference, NUI Galway
A Keohane, AM. Sullivan, Y. Nolan; (2008) -1 receptor antagonist prevents the effects of the pro-inflammatory cytokine, IL-1β on differentiating embryonic rat hippocampal neuronal precursor cells 2nd Neuroscience Ireland Conference, NUI Galway [Details]
(2008)2nd Neuroscience Ireland Conference
S. Ryan, E. Maloney, A. Keohane, A.M. Sullivan, Y. ; (2008) Tumour necrosis factor- affects the proliferation and differentiation of embryonic rat hippocampal neural precursor cells 2nd Neuroscience Ireland Conference [Details]
(2008)2nd Neuroscience Ireland Conference, NUI Galway
C.M. Long, A.M. Sullivan, Y. Nolan; (2008) The role of IL-1 in mediating the effects of LPS-stimulated rat glia on dopaminergic neuronal death in vitro 2nd Neuroscience Ireland Conference, NUI Galway [Details]
(2008)International neuroimmunology symposium
A Keohane, AM. Sullivan, Y. Nolan ; (2008) effect of the pro-inflammatory cytokine, TNFα, on the proliferation and differentiation of embryonic hippocampal neural cells International neuroimmunology symposium [Details]
(2008)International Neuroimmunology Symposium, Dublin
C.M. Long, A.M. Sullivan, Y. Nolan; (2008) IL-1β released from LPS-stimulated cortical glial cultures exacerbates 6-OHDA-induced dopaminergic neuronal cell death in vitro International Neuroimmunology Symposium, Dublin [Details]
(2007)British Neuroscience Association Abstract 19: P6.05
Keohane A, Sullivan AM, Nolan Y ; (2007) The effect of pro-inflammatory cytokines, IL-1β and TNFα on embryonic rat hippocampal neuronal precursor cells British Neuroscience Association Abstract 19: P6.05 [Details]
(2007)19th National Meeting of the British Neuroscience Association, Harrogate
Long, C., Sullivan, A.M., Nolan, Y. ; (2007) The effect of conditioned media from LPS-stimulated rat mixed glial cultures on 6-OHDA-treated rat ventral mesencephalic neurons in vitro 19th National Meeting of the British Neuroscience Association, Harrogate [Details]
(2007)XVIIth World Federation of Neurology World Congress on Parkinson¿s Disease and Related Disorders, Amsterdam
C. Long, A.M. Sullivan, Y.M. Nolan. ; (2007) The effect of p38 inhibition on the survival of 6-hydroxydopamine-treated rat ventral mesencephalic neurons in vitro XVIIth World Federation of Neurology World Congress on Parkinson¿s Disease and Related Disorders, Amsterdam [Details]
(2006)Society for Neuroscience Abstracts
S Crotty, P Fitzgerald, A Mandel, AE Bolton, AM Sullivan, Y Nolan. ; (2006) Treatment with a novel phospholipid-based drug formulation prevents behavioural deficits induced by proteasome inibition: implications for Parkinson¿s disease Society for Neuroscience Abstracts [Details]
(2006)
Crotty S, Fitzgerald P, Harris DM, Fisher A, Mandel A, Bolton AE, Sullivan AM, Nolan Y ; (2006) Neuroprotective evidence of a novel phospholipid-based drug formulation in a rat model of parkinson¿s disease [Details]
(2006)
CM Long, AM Sullivan, YM Nolan.; (2006) 6-hydroxydopamine induces a direct neurotoxic effect on embryonic rat midbrain dopaminergic neurons independent of microglial activation in vitro [Details]
(2006)
Keohane A, Sullivan AM, Nolan Y ; (2006) Characterisation of embryonic rat hippocampal neuronal precursor cells in neurosphere cultures [Details]
(2006)
S Crotty, P Fitzgerald, DM Harris, A Fisher, A Mandel, AE Bolton, AM Sullivan, Y Nolan.; (2006) 6-hydroxydopamine-induced p38 activation in rat nigral dopaminergic neurons is reduced by treatment with a novel phospholipid-based drug formulation [Details]
(2006)
C Long, Y Nolan Y, AM Sullivan; (2006) Effects of 6-hydroxydopamine on the survival of embryonic rat midbrain dopaminergic neurons in vitro [Details]
(2005)
R Barrett, K McDermott, AM Sullivan. ; (2005) The effects of astroglial and neurotrophic interactions on the survival of dopaminergic neurons in vitro [Details]
(2005)
R Flynn, D O¿Sullivan, AM Sullivan, P Harrison. ; (2005) Use of pCEP4 Vector for Simple and Rapid Establishment of Stable Cell-Lines and Long-Term Gene Expression [Details]
(2005)16th International Congress on Parkinson's Disease and Related Disorders
Toulouse A., Sullivan A.M.; (2005) Investigation of the neurotrophic effects of growth/differentiation factor 5 in an in vitro model of Parkinson's disease 16th International Congress on Parkinson's Disease and Related Disorders Berlin, Germany, , 05-JUN-05 - 09-JUN-05 [Details]
(2005)
TA Kelly, PT Harrison, MF Scallan, AM Sullivan.; (2005) Lentiviral-mediated delivery of growth/differentiation factor 5 attenuates parkinsonian symptoms in the rat [Details]
(2005)
DM Harris, A Fisher, A Mandel, AE Bolton, AM Sullivan, Y Nolan.; (2005) 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation [Details]
(2005)35th Annual Meeting of the Society for Neuroscience
Spitere K., Toulouse A.,Sullivan, A.M.; (2005) TAT-PAX6 protein transduction in neural progenitor cells: A novel strategy for dopaminergic neuron generation 35th Annual Meeting of the Society for Neuroscience Wahington DC, USA, , 12-NOV-05 - 16-NOV-05 [Details]
(2005)
DK Shanley, AM Sullivan; (2005) Identification, isolation and expansion of neuronal precursor cells: A step-by-step process involving microarray analysis, immunoselection and neurosphere culture [Details]
(2005)
DB O¿Sullivan, PT Harrison, YM Nolan, AM Sullivan. ; (2005) Prevention of apoptosis in cultured dopaminergic neurons by GDNF and GDF5 [Details]
(2005)
P Fitzgerald, D Harris, S Crotty, A Harkin, A Mandel, AE Bolton, AM Sullivan, Y Nolan. ; (2005) Treatment with a novel phospholipid-based drug formulation inhibits 6-hydroxydopamine-induced p38 activation in rat substantia nigra [Details]
(2005)International Conference on Parkinson's disease
Harris DM, Fisher A, Mandel A, Bolton AE, Sullivan AM, Nolan Y.; (2005) 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation . In: * eds. International Conference on Parkinson's disease Berlin, Germany, , 05-JUN-05 - 08-JUN-06 , pp.PT019-08-* [Details]
(2005)Society for Neuroscience
O’Sullivan DB, Harrison PT, Nolan YM, Sullivan AM; (2005) Prevention of apoptosis in cultured dopaminergic neurons by GDNF and GDF5 . In: * eds. Society for Neuroscience Washington DC, USA, , 12-NOV-05 - 16-NOV-05 , pp.889.12-* [Details]
(2005)
P Fitzgerald, DM Harris, S Crotty, A Fisher, A Mandel, AE Bolton, AM Sullivan, Y Nolan; (2005) 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation [Details]
(2005)Royal Academy of Medicine in Ireland, Biomedical Section
Harris DM, Fisher A, Harkin AJ, Bolton AE, Sullivan AM, Nolan YM; (2005) Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease . In: * eds. Royal Academy of Medicine in Ireland, Biomedical Section Dublin, Ireland, , 07-JAN-05 - 07-JAN-05 , pp.In Press-* [Details]
(2005)Society for Neuroscience
Fitzgerald P, Harris DM, Crotty S, Harkin A, Mandel A, Bolton AE, Sullivan AM, Nolan Y; (2005) Treatment with a novel phospholipid-based drug formulation inhibits 6-hydroxydopamine-induced p38 activation in rat substantia nigra . In: * eds. Society for Neuroscience Washington DC, USA, , 11-DEC-05 - 16-NOV-05 , pp.553.10-* [Details]

Conference Contributions

 YearPublication
(2007)Irish Network of Neural Stem Cell Investigators,
Sullivan, A.M.; (2007) . [Conference Organising Committee Member], Irish Network of Neural Stem Cell Investigators, Dublin , 01-JAN-07 - 01-JAN-07
(2006)Society for Neuroscience,
S Crotty, P Fitzgerald, A Mandel, AE Bolton, AM Sullivan, Y Nolan.; (2006) Treatment with a novel phospholipid-based drug formulation prevents behavioural deficits induced by proteasome inibition: implications for Parkinson’s disease. [Poster Presentation], Society for Neuroscience, Atlanta, Georgia, USA , 24-OCT-06 - 28-OCT-06
(2006)Irish Society for Gene and Cell Therapy meeting,
A.M. Sullivan; (2006) Neuroprotective and restorative therapies for Parkinson¿s disease. [Oral Presentation], Irish Society for Gene and Cell Therapy meeting, Galway , 01-JAN-06 - 01-JAN-06
(2006)Royal Irish Academy of Medicine,
S Crotty, P Fitzgerald, DM Harris, A Fisher, A Mandel, AE Bolton, AM Sullivan, Y Nolan. ; (2006) 6-hydroxydopamine-induced p38 activation in rat nigral dopaminergic neurons is reduced by treatment with a novel phospholipid-based drug formulation. [Poster Presentation], Royal Irish Academy of Medicine, Dublin, Ireland , 07-JAN-06 - 08-JAN-06
(2006)Royal Irish Academy of Medicine,
C Long, Y Nolan, AM Sullivan; (2006) Effects of 6-hydroxydopamine on the survival of embryonic rat midbrain dopaminergic neurons in vitro. [Poster Presentation], Royal Irish Academy of Medicine, Dublin, Ireland , 07-JAN-06 - 08-JAN-06
(2006)Irish Society for Gene and Cell Therapy meeting,
A.M. Sullivan; (2006) Neuroprotective and restorative therapies for Parkinson¿s disease. [Oral Presentation], Irish Society for Gene and Cell Therapy meeting, Galway , 01-JAN-06 - 01-JAN-06
(2006)Irish Network of Neural Stem Cell Investigators Sullivan,
Sullivan, A.M.; (2006) . [Conference Organising Committee Member], Irish Network of Neural Stem Cell Investigators Sullivan, Dublin , 01-JAN-06 - 01-JAN-06
(2006)5th Forum of European Neuroscience Societies,
CM Long, AM Sullivan, YM Nolan.; (2006) 6-hydroxydopamine induces a direct neurotoxic effect on embryonic rat midbrain dopaminergic neurons independent of microglial activation in vitro. [Poster Presentation], 5th Forum of European Neuroscience Societies, Vienna, Austria , 08-JUL-06 - 12-JUL-06
(2005)Meeting of the Physiological Society,
R Flynn, D O’Sullivan, AM Sullivan, P Harrison. ; (2005) Use of pCEP4 Vector for Simple and Rapid Establishment of Stable Cell-Lines and Long-Term Gene Expression. [Poster Presentation], Meeting of the Physiological Society, Bristol, UK , 02-AUG-05 - 04-AUG-05
(2005)Royal Irish Academy of Medicine,
DM Harris, A Fisher, AJ Harkin, AE Bolton, AM Sullivan, YM Nolan. ; (2005) Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease. . [Poster Presentation], Royal Irish Academy of Medicine, Dublin, Ireland , 05-JAN-05 - 06-JAN-05
(2005)16th International Conference on Parkinson's Disease,
DM Harris, A Fisher, A Mandel, AE Bolton, AM Sullivan, Y Nolan.; (2005) 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation. [Poster Presentation], 16th International Conference on Parkinson's Disease, Berlin, Germany , 05-JUN-05 - 09-JUN-05
(2005)Irish Network of Neural Stem Cell Investigators,
Sullivan, A.M.; (2005) . [Conference Organising Committee Member], Irish Network of Neural Stem Cell Investigators, Dublin , 01-JAN-05 - 01-JAN-05
(2005)School of Biosciences,
Sullivan, A.M.; (2005) GDF5 and neural stem cells for the treatment of Parkinson¿s disease. [Oral Presentation], School of Biosciences, Cardiff University , 01-JAN-05 - 01-JAN-05
(2005)Launch of Institute of Neuroscience,
Sullivan, A.M.; (2005) Neuroprotective therapies. [Invited Oral Presentation], Launch of Institute of Neuroscience, Trinity College Dublin , 01-JAN-05 - 01-JAN-05
(2005),
A.M. Sullivan; (2005) GDF5 and neural stem cells for the treatment of Parkinson¿s disease. [Oral Presentation], , School of Biosciences Cardiff University , 01-JAN-05 - 01-JAN-05
(2005),
A.M. Sullivan; (2005) Neuroprotective therapies for Parkinson¿s disease. [Oral Presentation], , launch of Institute of Neuroscience Trinity College Dublin , 01-JAN-05 - 01-JAN-05
(2005)Royal Irish Academy of Medicine ,
P Fitzgerald, DM Harris, S Crotty, A Fisher, A Mandel, AE Bolton, AM Sullivan, Y Nolan; (2005) 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation. [Poster Presentation], Royal Irish Academy of Medicine , Dublin, Ireland , 05-JUN-05 - 06-JUN-05
(2005)Society for Neuroscience,
K Spitere, A Toulouse, AM Sullivan.; (2005) TAT-Pax6 protein transduction in neural progenitor cells: A novel strategy for dopaminergic neuron generation. [Poster Presentation], Society for Neuroscience, Washington, DC, USA , 12-NOV-05 - 16-NOV-05
(2005)Society for Neuroscience,
DK Shanley, AM Sullivan; (2005) Identification, isolation and expansion of neuronal precursor cells: A step-by-step process involving microarray analysis, immunoselection and neurosphere culture. [Poster Presentation], Society for Neuroscience, Washington, DC, USA , 12-NOV-05 - 16-NOV-05
(2005)Society for Neuroscience ,
DB O’Sullivan, PT Harrison, YM Nolan, AM Sullivan.; (2005) Prevention of apoptosis in cultured dopaminergic neurons by GDNF and GDF5. [Poster Presentation], Society for Neuroscience , Washington, DC, USA , 12-NOV-05 - 16-NOV-05
(2005)Society for Neuroscience ,
P Fitzgerald, D Harris, S Crotty, A Harkin, A Mandel, AE Bolton, AM Sullivan, Y Nolan.; (2005) Treatment with a novel phospholipid-based drug formulation inhibits 6-hydroxydopamine-induced p38 activation in rat substantia nigra. [Poster Presentation], Society for Neuroscience , Washington, DC, USA , 12-NOV-05 - 16-NOV-05
(2005)16th International Conference on Parkinson's Disease,
TA Kelly, PT Harrison, MF Scallan, AM Sullivan.; (2005) Lentiviral-mediated delivery of growth/differentiation factor 5 attenuates parkinsonian symptoms in the rat. [Poster Presentation], 16th International Conference on Parkinson's Disease, Berlin, Germany , 05-JUN-05 - 09-JUN-05
(2005)16th International Conference on Parkinson's Disease,
A Toulouse, AM Sullivan ; (2005) Investigation of the neurotrophic effects of growth/differentiation factor 5 in an in vitro model of Parkinson' s disease. [Poster Presentation], 16th International Conference on Parkinson's Disease, Berlin, Germany , 05-JUN-05 - 09-JUN-05
(2005)7th European Meeting in Glial Cell Function in Health and Disease,
R Barrett, K McDermott, AM Sullivan. ; (2005) The effects of astroglial and neurotrophic interactions on the survival of dopaminergic neurons in vitro. [Poster Presentation], 7th European Meeting in Glial Cell Function in Health and Disease, Amsterdam, Holland , 20-MAY-05 - 23-MAY-05
(2004)Physiological Society meeting,
TA Kelly, PT Harrison, MF Scallan, AM Sullivan. ; (2004) Viral vectors to deliver neurotrophin genes to a rat model of Parkinson’s disease. [Poster Presentation], Physiological Society meeting, Bristol, UK , 11-SEP-04 - 12-SEP-04
(2004)Anatomical Society of Great Britain and Ireland Summer Meeting,
Crotty S, Sullivan AM, So KF, Chau WKD, Sharma AK, Dockery, P.; (2004) Cytoskeletal Reorganisation in Neurons: A Stereological Approach. [Poster Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Cork, Ireland , 06-AUG-04 - 08-AUG-04
(2004)Anatomical Society of Great Britain and Ireland Summer Meeting,
Clayton KB, Sullivan AM.; (2004) Investigation of the spatio-temporal pattern of expression of the neurotrophin growth/differentiation factor 5 in the developing and adult rat brain. [Poster Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Cork, Ireland , 06-AUG-04 - 08-AUG-04
(2004)Anatomical Society of Great Britain and Ireland Summer Meeting,
Barrett RJ, McDermott KW, Sullivan AM.; (2004) The effects of GDNF GDF5 and astroglia on the survival of rat mesencephalic dopaminergic neurons in vitro. [Poster Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Cork, Ireland , 06-AUG-04 - 08-AUG-04
(2004)15th Biennial Meeting of the International Society for Developmental Neuroscience,
Spitere KM, Sullivan AM.; (2004) A comparison of genetic cascades involved in induction of dopaminergic neuronal fate in the developing rodent ventral mesencephalon embryonic stem cells and neural stem cells. [Poster Presentation], 15th Biennial Meeting of the International Society for Developmental Neuroscience, Edinburgh, UK , 04-AUG-04 - 07-AUG-04
(2004)15th Biennial Meeting of the International Society for Developmental Neuroscience,,
Shanley DK, Sullivan AM.; (2004) Expression and characterisation of the neuronal cell surface markers 2F7 and E-NCAM within the developing rat brain: An in vitro analysis of the development of neuronal restricted precursors. [Poster Presentation], 15th Biennial Meeting of the International Society for Developmental Neuroscience,, Edinburgh, UK , 04-AUG-04 - 07-AUG-04
(2004)Anatomical Society of Great Britain and Ireland Summer Meeting,
O’Sullivan DB, Harrison PT, Sullivan AM.; (2004) Rat ventral mesencephalic cultures transfected with a plasmid expressing growth/differentiation factor 5 exhibit improved dopaminergic neuronal survival. [Poster Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Cork, Ireland , 06-AUG-04 - 08-AUG-04
(2004)Anatomical Society of Great Britain and Ireland Summer Meeting,
Harty M, Sullivan AM, McDermott K.; (2004) Astroglial diversity in dopaminergic nuclei implications for selective neuronal degeneration and Parkinson’s disease. [Poster Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Cork, Ireland , 06-AUG-04 - 08-AUG-04
(2004)Anatomical Society of Great Britain and Ireland Summer Meeting,
Kelly TA, Harrison PT, Scallan MF, Sullivan AM.; (2004) Viral vectors to deliver neurotrophin genes to a rat model of Parkinson's disease . [Poster Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Cork, Ireland , 06-AUG-04 - 08-AUG-04
(2004)34th Annual Meeting of the Society for Neuroscience,
Toulouse A, Sullivan AM.34th Annual Meeting of the Society for Neuroscience, San Diego USA; (2004) Roles of type 1 BMP receptors in the induction of midbrain dopaminergic neurones by GDF5. [Poster Presentation], 34th Annual Meeting of the Society for Neuroscience, San Diego USA , 23-OCT-04 - 27-OCT-04
(2004)34th Annual Meeting of the Society for Neuroscience,
O’Keeffe GW, Toulouse A, Sullivan AM.; (2004) Dopaminergic induction from expanded rat ventral mesencephalic progenitor cells by GDF5 and BMP2 requires signalling through BMPR-Ib. [Poster Presentation], 34th Annual Meeting of the Society for Neuroscience, San Diego, USA , 23-OCT-04 - 27-OCT-04
(2004)34th Annual Meeting of the Society for Neuroscience,
Fisher A, Harris DM, Harkin AJ, Bolton AE, Sullivan AM, Nolan YM.; (2004) Novel phospholipid-based drug formulation retards the 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons. [Poster Presentation], 34th Annual Meeting of the Society for Neuroscience, San Diego USA , 23-OCT-04 - 27-OCT-04
(2004)Anatomical Society of Great Britain and Ireland Summer Meeting,
Spitere KM, Sullivan AM.; (2004) Characterisation of the cellular populations and dopaminergic gene cascade in rat ventral mesencephalic neural stem cell cultures. [Poster Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Cork, Ireland , 06-AUG-04 - 06-AUG-04
(2004)Anatomical Society of Great Britain and Ireland Summer Meeting,
Shanley DK, Sullivan AM.; (2004) In vitro expansion and differentiation of neurospheres derived from embryonic day 14 rat cortical and striatal tissue. [Poster Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Cork, Ireland , 06-AUG-04 - 08-AUG-04
(2004)4th Forum of European Neuroscience,
Toulouse A, Sullivan AM.; (2004) Investigation of the role of GDF-5 in the growth and differentiation of human neuroblastoma cells. [Poster Presentation], 4th Forum of European Neuroscience, Lisbon, Portugal , 10-JUL-04 - 14-JUL-04
(2004)4th Forum of European Neuroscience,
Spitere KM, Sullivan AM.; (2004) Cellular composition and gene expression in embryonic rat ventral mesencephalic neurosphere cultures . [Poster Presentation], 4th Forum of European Neuroscience, Lisbon, Portugal , 10-JUL-04 - 14-JUL-04
(2004)4th Forum of European Neuroscience,
Shanley DK, Sullivan AM.; (2004) Cellular differentiation in neurosphere cultures of embryonic day 14 rat cortical and striatal tissue. [Poster Presentation], 4th Forum of European Neuroscience, Lisbon, Portugal , 10-JUL-04 - 14-JUL-04
(2004)4th Forum of European Neuroscience,
O’Sullivan DB, Harrison PT, Sullivan AM.; (2004) Establishment of neurotrophin-expressing dopaminergic cells for transplantation in Parkinson’s disease. [Poster Presentation], 4th Forum of European Neuroscience, Lisbon, Portugal , 10-JUL-04 - 14-JUL-04
(2004)4th Forum of European Neuroscience,
Clayton KB, Sullivan AM.; (2004) Growth/differentiation factor-5 (GDF-5) expression in the developing and adult rat brain. [Poster Presentation], 4th Forum of European Neuroscience, Lisbon, Portugal , 10-JUL-04 - 14-JUL-04
(2004)4th Forum of European Neuroscience,
Barrett RJ, McDermott KW, Sullivan AM.; (2004) The roles of GDNF GDF-5 and astroglia on the survival of mesencephalic dopaminergic neurons in vitro. [Poster Presentation], 4th Forum of European Neuroscience, Lisbon, Portugal , 10-JUL-04 - 14-JUL-04
(2004)Anatomical Society of Great Britain and Ireland Summer Meeting,
Toulouse A, Sullivan AM.; (2004) Investigation of the effects of the neurotrophin GDF-5 on the growth and differentiation of SHSY-5Y cells. [Poster Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Cork, Ireland , 06-AUG-04 - 08-AUG-04
(2004)Anatomical Society of Great Britain and Ireland Summer Meeting,
Sullivan AM.; (2004) Effects of growth / differentiation factor 5 (GDF5) on the induction and survival of midbrain dopaminergic neurones. [Invited Oral Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Cork, Ireland , 06-AUG-04 - 08-AUG-04
(2004)Anatomical Society of Great Britain and Ireland,
Sullivan, A.M.; (2004) . [Conference Organising Committee Member], Anatomical Society of Great Britain and Ireland, Cork , 01-JAN-04 - 01-JAN-04
(2004)Irish Network of Neural Stem Cell Investigators,
Sullivan, A.M.; (2004) . [Conference Organising Committee Member], Irish Network of Neural Stem Cell Investigators, Dublin , 01-JAN-04 - 01-JAN-04
(2004)Anatomical Society of Great Britain and Ireland meeting,
Sullivan, A.M.; (2004) Effects of GDF5 on the induction and survival of dopaminergic neurones. [Oral Presentation], Anatomical Society of Great Britain and Ireland meeting, Cork , 01-JAN-04 - 01-JAN-04
(2004)Irish Network of Stem Cell Investigators meeting,
Sullivan, A.M.; (2004) Neuronal stem cells for the treatment of Parkinson¿s disease. [Oral Presentation], Irish Network of Stem Cell Investigators meeting, Dublin , 01-JAN-04 - 01-JAN-04
(2003)6th International Conference on Alzheimer`s and Parkinson`s Disease,
Costello DJ, O’Keeffe GW, Hurley FM, Hanke M, Sullivan AM.; (2003) A growth/differentiation factor 5-producing CHO cell line enhances the survival and function of dopaminergic grafts in a 6-OHDA rodent model of Parkinsonism. [Oral Presentation], 6th International Conference on Alzheimer`s and Parkinson`s Disease, Seville Spain , 08-MAY-03 - 12-MAY-03
(2003)Anatomical Society of Great Britain and Ireland Winter Meeting,,
O'Keeffe GW, Hanke M, Sullivan AM.; (2003) Growth/differentiation factor-5, a growth factor with potential for therapeutic approaches for Parkinson's disease . [Oral Presentation], Anatomical Society of Great Britain and Ireland Winter Meeting,, Egham, UK , 07-JAN-03 - 09-JAN-03
(2003)Brain Repair Group,
Sullivan, A.M.; (2003) GDF-5: a dopaminergic neurotrophin with potential for use in Parkinson¿s disease. [Oral Presentation], Brain Repair Group, Cardiff University , 01-JAN-03 - 01-JAN-03
(2003),
Sullivan, A.M.; (2003) Neuroprotective approaches to the treatment of Parkinson¿s disease. [Oral Presentation], , Dept. of Zoology Trinity College Dublin , 01-JAN-03 - 01-JAN-03
(2003)Anatomical Society of Great Britain and Ireland,
GW O’Keeffe, M Hanke, AM Sullivan.; (2003) Growth/differentiation factor-5, a growth factor with potential for therapeutic approaches to Parkinson’s disease. [Poster Presentation], Anatomical Society of Great Britain and Ireland, Egham,UK , 07-JAN-03 - 10-JAN-03
(2003)Alzheimer’s and Parkinson’s diseases: New perspectives,,
DJ Costello, GW O’Keeffe, FM Hurley, M Hanke, AM Sullivan.; (2003) A growth/differentiation factor 5-producing CHO cell line enhances the survival and function of dopaminergic grafts in a 6-OHDA rodent model of Parkinsonism. [Poster Presentation], Alzheimer’s and Parkinson’s diseases: New perspectives,, Seville, Spain , 08-MAY-03 - 12-MAY-03
(2003)3rd Forum of European Neuroscience,
Wood TK, Sullivan AM, McDermott KW.; (2003) In vitro analysis of the effects of the neurotrophins GDF-5 GDNF and glial cells on dopaminergic neurone survival in the ventral mesencephalon. [Poster Presentation], 3rd Forum of European Neuroscience, Paris, France , 13-JUL-03 - 17-JUL-03
(2003)5th European Meeting on Glial Cell Function in Health and Disease,
Wood TK, Sullivan AM, McDermott KW.; (2003) In vitro analysis of astroglial-neuronal interactions in the ventral mesencephlon. [Poster Presentation], 5th European Meeting on Glial Cell Function in Health and Disease, Rome, Ital , 21-MAY-03 - 25-MAY-03
(2002)Irish Neuroscience Group meeting,
Sullivan, A.M.; (2002) Neuroprotective and restorative approaches to Parkinson¿s disease. [Oral Presentation], Irish Neuroscience Group meeting, Tullamore , 01-JAN-02 - 01-JAN-02
(2002)National Parkinson's Disease Study Day,
Sullivan, A.M.; (2002) Stem cells and growth factors for Parkinson¿s disease. [Oral Presentation], National Parkinson's Disease Study Day, Dublin , 01-JAN-02 - 01-JAN-02
(2002)3rd Forum of European Neuroscience,
O’Keeffe GW, Costello DJ, Sullivan AM.; (2002) Expression of the dopaminergic neurotrophin Growth differentiation factor-5 in the developing ventral mesencephalon and its effect on the differentiation of neural stem cells. [Poster Presentation], 3rd Forum of European Neuroscience, Paris, France , 13-JUL-02 - 17-JUL-02
(2002)Anatomical Society of Great Britain and Ireland,
GW O’Keeffe, DJ Costello, AM Sullivan.; (2002) Growth/differentiation factor-5: developmental regulator, potential treatment. [Poster Presentation], Anatomical Society of Great Britain and Ireland, Dundee, Scotland , 23-JUL-02 - 26-JUL-02
(2002)Anatomical Society of Great Britain and Ireland Summer Meeting,
O'Keeffe GW, Hanke M, Sullivan AM.; (2002) Growth/differentiation factor-5 (GDF-5) and dopaminergic neurones: developmental regulator potential treatment. [Oral Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Dundee, Scotland , 23-JUL-02 - 25-JUL-02
(2002)3rd Forum of European Neuroscienc,
O'Keeffe GW, Hanke M, Sullivan AM.; (2002) Restorative effects of growth/differentiation factor-5 (GDF-5) in a rat model of Parkinson's disease. [Poster Presentation], 3rd Forum of European Neuroscienc, Paris, France , 13-JUL-02 - 17-JUL-02
(2001)Beaumont Hospital Neurology meeting,
Sullivan, A.M.; (2001) Cell transplantation for Parkinson¿s disease. [Oral Presentation], Beaumont Hospital Neurology meeting, Dublin , 01-JAN-01 - 01-JAN-01
(2001)Anatomical Society of Great Britain and Ireland Summer Meeting,
Wood TK, Sullivan AM, McDermott KW.; (2001) Antimitotic treatment to achieve neurone enriched ventral mesencephalic cultures for studies of neurotrophins. [Poster Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Dublin, Ireland , 10-JUL-01 - 12-JUL-01
(2001)Anatomical Society of Great Britain and Ireland Summer Meeting,
Hurley FM, Costello DJ, Sullivan AM.; (2001) Neuroprotective effects of growth/differentiation factor-5 in a rat model of Parkinson's disease. [Poster Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Dublin, Ireland , 10-JUL-01 - 12-JUL-01
(2001)Anatomical Society of Great Britain and Ireland Summer Meeting,
Costello DJ, Hurley FM, Sullivan AM.; (2001) Growth/differentiation factor-5 enhances graft survival and reverses motor asymmetry in a rat model of Parkinson's disease. [Poster Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, Dublin, Ireland, , 10-JUL-01 - 12-JUL-01
(2001)Anatomical Society of Great Britain and Ireland Summer Meeting, 10-12th July 2001,
O'Keeffe GW, Sullivan AM.; (2001) Investigation of the expression of growth/differentiation factor-5 in the developing rat brain. [Poster Presentation], Anatomical Society of Great Britain and Ireland Summer Meeting, 10-12th July 2001, Dublin, Ireland , 10-JUL-01 - 12-JUL-01
(2000)Mater Hospital Neurology meeting,
Sullivan, A.M.; (2000) Neuroprotective approaches to Parkinson¿s disease. [Oral Presentation], Mater Hospital Neurology meeting, Dublin , 01-JAN-00 - 01-JAN-00
(2000)2nd Forum of European Neuroscience,
Wood TK, McDermott KW, Sullivan AM.; (2000) Glia-depleted mesencephalic cultures for investigation of the action of the dopaminergic neurotrophins GDF-5 and GDNF. [Poster Presentation], 2nd Forum of European Neuroscience, Brighton, UK , 24-JUN-00 - 28-JUN-00
(1999)Irish Neuroscience Group meeting,
Sullivan, A.M.; (1999) GDF5, a neurotrophic factor with potential for Parkinson¿s disease. [Oral Presentation], Irish Neuroscience Group meeting, Galway , 01-JAN-99 - 01-JAN-99
(1998)Charing Cross & Westminster Hospital Neuroscience meeting,
Sullivan, A.M.; (1998) GDF5, a neuroprotective protein with potential for Parkinson¿s disease treatment. [Oral Presentation], Charing Cross & Westminster Hospital Neuroscience meeting, London , 01-JAN-98 - 01-JAN-98
(1998)Hammersmith Hospital Neurology meeting,
Sullivan, A.M.; (1998) Effects of GDF5 and GDNF in animal models of Parkinson¿s disease. [Oral Presentation], Hammersmith Hospital Neurology meeting, London , 01-JAN-98 - 01-JAN-98
(1997)27th Annual Meeting of the Society for Neuroscience,
Sullivan AM, Opacka-Juffry J, Hotten G, Pohl J, Blunt SB.; (1997) Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson’s disease. [Poster Presentation], 27th Annual Meeting of the Society for Neuroscience, New Orleans, USA , 25-OCT-97 - 30-OCT-97
(1997)XIIth International Symposium on Parkinson's Disease,
Sullivan AM, Opacka-Juffry J, Blunt SB.; (1997) Long-term protection of the rat nigrostriatal dopaminergic system by GDNF in vivo. [Poster Presentation], XIIth International Symposium on Parkinson's Disease, London, UK , 23-MAR-97 - 26-MAR-97
(1997)14th Meeting of Brain Research Association,
Sullivan AM, Opacka-Juffry J, Blunt SB.; (1997) Long-term protection of the rat nigrostriatal dopaminergic system by GDNF in vivo. [Poster Presentation], 14th Meeting of Brain Research Association, Liverpool, UK , 07-APR-97 - 09-APR-97
(1996)13th Meeting of Brain Research Association,
Ashworth S, Opacka-Juffry J, Sullivan AM, Banati RB, Blunt SB.; (1996) Lack of functional nigrostriatal dopamine deficit following 6-hydroxydopamine injection into the striatum. [Poster Presentation], 13th Meeting of Brain Research Association, Newcastle, UK , 25-MAR-96 - 27-MAR-96
(1995)12th Meeting of Brain Research Association,
Sullivan AM, Morton AJ.; (1995) Induction of Fos protein in organotypic cultures of rat cerebellum by endothelins. [Poster Presentation], 12th Meeting of Brain Research Association, Oxford, UK , 29-MAR-95 - 31-MAR-95
(1994)11th Meeting of Brain Research Association,
Sullivan AM, Morton AJ.; (1994) Glutamate-induced expression of Fos protein by granule cells in organotypic cultures of rat cerebellum. [Poster Presentation], 11th Meeting of Brain Research Association, Southampton, UK , 10-APR-94 - 13-APR-94
(1994)11th Meeting of Brain Research Association,
Sullivan AM, Morton AJ.; (1994) Is the development of Purkinje cell dendrites in organotypic culture of rat cerebellum dependent on granule cells?. [Poster Presentation], 11th Meeting of Brain Research Association, Southampton, UK , 10-APR-94 - 13-APR-94

Committees

 CommitteeFunctionFrom / To
Irish Network of Neural Stem Cell Investigators Committee member2004 / 1899
Anatomical Society of Great Britain and Ireland Committee member2006 / 1899
External PhD examiner 2003 / 2003
External PhD examiner 2005 / 2005
External PhD examiner 2007 /
External MSc examiner 2007 / 2007
Grant reviewer Parkinson¿s Disease Society, London /
Grant reviewer HRB ¿Neuroscience Clinical Neurolgy and Mental Health¿ panel /
Grant reviewer Wellcome Trust, London 2006-present /
Grant reviewer Medical Research Council Trust, London 2006-present /
Grant reviewer National University of Ireland 2006-present /

Employment

 EmployerPositionFrom / To
Anatomy UCC Senior Lecturer01-OCT-98 /
University College Cork College Lecturer01-OCT-98 / 30-SEP-06
Imperial College London Post-doctoral researcher01-OCT-95 / 30-SEP-98

Education

 YearInstituionQualificationSubject
2005University College Cork Postgraduate Certificate in Teaching and Learning in Higher Ed.
1992University College Dublin BSc
1995University of Cambridge PhD

Reviews

 JournalRole
European Journal Of Neuroscience Referee
Neuroscience Referee
Experimental Neurology Referee
Journal Of Neuroscience Referee
Neuroreport Referee
Brain Research Referee
Neuroscience Letters Referee
Journal Of Neural Transmission Referee
Journal Of Neuroscience Methods Referee
Journal Of Anatomy Referee
Journal Of Anatomy Editor
 Term (ID))TitleLinkSubject
2014Research Project AN4010Research Project
2014Mammalian Cell and Tissue Structure AN2007Mammalian Cell and Tissue Structure
2014Mammalian Cell and Tissue Structure AN2004Mammalian Cell and Tissue Structure
2014Neurobiology of Regulatory Systems AN3003Neurobiology of Regulatory Systems
2014Research Project AN4011Research Project
2014Anatomy and Introductory Pathophysiology AN1074Anatomy and Introductory Pathophysiology
2014Behavioural and Cognitive Neuroscience AN4009Behavioural and Cognitive Neuroscience